Topic: Breast Neoplasms
Journal: Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Documents
A list of abstracts that contain a topic of "Breast Neoplasms" and a journal name of "Clinical Cancer Research : an Official Journal of the American Association for Cancer Research".
Changes of Topoisomerase Iialpha Expression in Breast Tumors After Neoadjuvant Chemotherapy Predicts Relapse-free Survival.
PMID: 16533774
Identification of Ntn4, Tra1, and Stc2 As Prognostic Markers in Breast Cancer in a Screen for Signal Sequence Encoding Proteins.
PMID: 17545519
A Phase I Study of Oncovexgm-csf, a Second-generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-stimulating Factor.
PMID: 17121894
Tumor Antigen-specific T-cell Expansion is Greatly Facilitated by in Vivo Priming.
PMID: 17363545
Functional Plasminogen Activator Inhibitor-1 Gene Variants and Breast Cancer Survival.
PMID: 17062678
4e-binding Protein 1, a Cell Signaling Hallmark in Breast Cancer That Correlates with Pathologic Grade and Prognosis.
PMID: 17200342
Multistate Analysis of Skeletal Events in Patients with Bone Metastases.
PMID: 17062711
Anastrozole Versus Tamoxifen Treatment in Postmenopausal Women with Endocrine-responsive Breast Cancer and Tamoxifen-induced Endometrial Pathology.
PMID: 16489080
The Cyclooxygenase-2 (Ptgs2) 8473t>c Polymorphism is Associated with Breast Cancer Risk.
PMID: 16489098
Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype.
PMID: 17020963
Flaxseed and Its Lignans Inhibit Estradiol-induced Growth, Angiogenesis, and Secretion of Vascular Endothelial Growth Factor in Human Breast Cancer Xenografts in Vivo.
PMID: 17289903
Epigenetic Inactivation Implies Independent Functions for Insulin-like Growth Factor Binding Protein (Igfbp)-related Protein 1 and the Related Igfbpl1 in Inhibiting Breast Cancer Phenotypes.
PMID: 17634530
Correlations Between Serum Monocyte Chemotactic Protein-1 Levels, Clinical Prognostic Factors, and Her-2/Neu Vaccine-related Immunity in Breast Cancer Patients.
PMID: 16428490